Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-028451

President and CEO sold 30,000 shares at $26.84 ($805,239)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2021-04-22 Sale −30,000 $26.84 $805,239 1,192,427 D
Open-market sales · 30,000 sh · avg $26.84 · $805,239
Loading xslF345X03/doc4.xml…